付辰星于南方医科大学获得内科学专业博士学位，于2020年加入GMU iCAN Lab，现为广州医科大学生物医学工程学院教授、硕士生导师。近5年主要围绕“心血管疾病的纳米免疫疗法”开展研究。研究方向包括：①基于动脉斑块靶向的免疫调控；②基于血液单核细胞靶向的免疫调控；③基于脾脏靶向的心脾轴免疫调控。
Dr. Chenxing Fu obtained his Ph.D. in Internal Medicine from Southern Medical University. He joined the GMU iCAN Lab in 2020 and is currently a professor and master's supervisor at the School of Biomedical Engineering, Guangzhou Medical University. Over the past five years, his research has primarily focused on "nano-immunotherapy for cardiovascular diseases." His research directions include: ① immune regulation based on arterial plaque targeting; ② immune regulation based on blood monocyte targeting; and ③ heart-spleen axis immune regulation based on spleen targeting.
E-mail: fuxing19930523@163.com